- Home
- PPBT vs EFOI Comparison
PPBT vs EFOI Comparison
Compare PPBT & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- EFOI
- Stock Information
- Founded
- PPBT 2010
- EFOI 1985
- Country
- PPBT Israel
- EFOI United States
- Employees
- PPBT N/A
- EFOI N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- EFOI Building Products
- Sector
- PPBT Health Care
- EFOI Consumer Discretionary
- Exchange
- PPBT Nasdaq
- EFOI Nasdaq
- Market Cap
- PPBT 6.3M
- EFOI 12.1M
- IPO Year
- PPBT N/A
- EFOI 1994
- Fundamental
- Price
- PPBT $2.37
- EFOI $2.40
- Analyst Decision
- PPBT Strong Buy
- EFOI
- Analyst Count
- PPBT 1
- EFOI 0
- Target Price
- PPBT $33.00
- EFOI N/A
- AVG Volume (30 Days)
- PPBT 26.3K
- EFOI 21.9K
- Earning Date
- PPBT 08-15-2025
- EFOI 08-12-2025
- Dividend Yield
- PPBT N/A
- EFOI N/A
- EPS Growth
- PPBT N/A
- EFOI N/A
- EPS
- PPBT N/A
- EFOI N/A
- Revenue
- PPBT N/A
- EFOI $4,643,000.00
- Revenue This Year
- PPBT N/A
- EFOI N/A
- Revenue Next Year
- PPBT N/A
- EFOI N/A
- P/E Ratio
- PPBT N/A
- EFOI N/A
- Revenue Growth
- PPBT N/A
- EFOI N/A
- 52 Week Low
- PPBT $2.00
- EFOI $1.14
- 52 Week High
- PPBT $13.95
- EFOI $2.95
- Technical
- Relative Strength Index (RSI)
- PPBT 42.59
- EFOI 61.50
- Support Level
- PPBT $2.25
- EFOI $1.64
- Resistance Level
- PPBT $2.45
- EFOI $2.48
- Average True Range (ATR)
- PPBT 0.13
- EFOI 0.20
- MACD
- PPBT -0.02
- EFOI 0.05
- Stochastic Oscillator
- PPBT 21.11
- EFOI 81.13
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.